The Efficacy of Cabazitaxel in Treating Prostate Cancer: A Systematic Review and Meta-Analysis

Cabazitaxel, a second-generation taxane chemotherapy agent, has demonstrated efficacy in treating metastatic castration-resistant prostate cancer (mCRPC) in patients who have previously received docetaxel-based therapy. By targeting microtubule dynamics, cabazitaxel inhibits cancer cell division and...

Szczegółowa specyfikacja

Opis bibliograficzny

Główni autorzy:	Hashim Talib Hashim, Mudassir Ahmad Khan, Safa Irfan Shah, Mohammedbaqer Ali Al-Ghuraibawi, Fatimah Abdullah Sulaiman, Jamil Nasrallah, Ralph Maroun, Ali Talib Hashim, Naseer Ahmed, Zahraa Hamaza Merza
Format:	Artigo
Język:	Inglês
Wydane:	SAGE Publishing 2024-10-01
Seria:	American Journal of Men's Health
Dostęp online:	https://doi.org/10.1177/15579883241285162
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!